Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Announces Q1 Production 201,101 Ounces Silver and 7,545 Ounces Gold

Vancouver, British Columbia - April 15, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to announce silver and gold production numbers for the first quarter of 2014 from its 100% owned Santa Elena Mine located in Sonora, Mexico. For additional information and to view photos and videos, please visit the Company’s website at www.silvercrestmines.com.

Production Highlights of Q1, 2014 vs. Q1, 2013;

• Silver production of 201,101 ounces; a 31% increase.
• Gold production of 7,545 ounces; a 4% increase.
• Silver equivalent (1) production of 653,801 ounces; a 17% increase.
• Waste to ore ratio of 0.94 was consistent with the mine plan; a 78% decrease.
• Ore Tonnes crushed decreased 21% to 200,982 tonnes with throughput averaging 2,233 tpd .
• Average grades loaded on pad increased from 62.1gpt to 86.8 gpt (40%) for silver and from 1.54 to 1.79 gpt (16%) for gold.

N. Eric Fier, President and COO stated ; “During the first three months of 2014, Santa Elena experienced lower ore and waste tonnes mined from the open pit as it approached the end of its mine life. However, metal production exceeded corporate guidance projections for the quarter. The Company continues to focus on the completion stages of the Santa Elena Expansion Plan which should significantly increase our annual precious metal production starting in mid-2014. The recently announced pit closure at Santa Elena may have some impact on Q2 production but SilverCrest maintains the previously announced 2014 corporate production guidance of 3.3 to 3.6 million ounces AgEq (60:1). ”
(1) Silver equivalent ("AgEq") ounces consist of the number of ounces of silver production/sold plus the number of ounces of gold production/sold multiplied by 60:1 gold price to silver price ratio, as determined in the 2014 budget, prior to Q1 2014, the AgEq ratio was based on the spot gold price to the spot silver price at the quarter end dates for financial reporting. All numbers are rounded.
First quarter of 2014 metal production was down 12% and 18% for silver and gold, respectively, compared to Q4, 2013. The decrease in silver and gold production was related to reduced ore tonnes mined and crushed in Q1 2014, which was somewhat offset by higher gold and silver grades. Open pit mining and crushing activities were reduced in Q1 and ultimately discontinued on April 04, 2014. No further ore will be loaded on the leach pad with ongoing stockpiling of high grade underground ore for milling. Silver and gold production will continue from the pad until at least August 2014.
SilverCrest is now focusing on the accelerated development of the underground mine at Santa Elena with 2,480 metres of the main ramp driven to date (570m level), which will provide access to high grade mill feed starting in Q2 2014. Initially, the mill will process leach pad ore only and underground ore will be stockpiled. In late Q2, blending of leach pad and underground ore should begin with testing of optimal mix ratios in H2, 2014.
First Quarter Financial Results Release:
The Company plans to issue its first quarter financial results on Thursday, May 15, 2014.
The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, President and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (NYSE MKT: SVLC; TSX: SVL) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest’s flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and operating cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State, Mexico.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
N. Eric Fier, President & COO
SILVERCREST MINES INC.
Neither TSX Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Fred Cooper
Telephone: (604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
Email: info@silvercrestmines.com
Website: www.silvercrestmines.com
Address: Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Breaking Tech News: NXT-ID's (OTCQB: NXTD) Dynamic Pairing Prevents Security Vulnerabilities Such as Heartbleed Security Leak

SHELTON, CT - April 14, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today solutions to prevent issues such as the Heartbleed OpenSSL security leak using its patent pending Dynamic Pairing.

Gino Pereira, CEO of Nxt-ID said, "Dynamic Pairing is an important part of our MobileBio® product offerings including Wocket™. What sets us apart is that we not only authenticate who you are to access your private information, but we also protect it through sophisticated and novel encryption methods."
OpenSSL, a widely used open-source encryption standard, recently became the source of one of the largest security flaws ever reported. A little more than half the Internet is secured with OpenSSL, not including all the various email, chat, and app services on various platforms. The security flaw takes advantage of what OpenSSL calls a "heartbeat," where data is exchanged between a device and a server. Under normal circumstances, a device can only request a specific amount of data from the service. However, a recent bug introduced into the OpenSSL codebase allowed more than the specific amount to be extracted, causing more information to be revealed to the device than the device should be authorized to receive.
NXT-ID's Dynamic Pairing has its own heartbeat method, but unlike other methods such as OpenSSL, each data request is dynamic and based upon a risk analysis algorithm that inherently validates authentication. Since, by its very nature, authentication under dynamic pairing changes with each access, unauthorized data can never be revealed to any device. Dynamic Pairing adds authentication and security that overcome traditional vulnerabilities of methods such SSL and TLS.
In the case of Heartbleed, a hacker is accessing data over what the server assumed to be, a secure channel. The hacker then uses that channel to continually probe the server for more and more data. With Dynamic Pairing, the authentication score determines the level of trust the server gives an incoming connection. When a server utilizes Pairing Codes which are encrypted with dynamic authentication scores, a server would not be susceptible to an attack like Heartbleed.

About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Stevia / LOHAS Stock Alert: GLG (TSX: GLG) Announces High Purity Reb M GRAS Notification With FDA

Vancouver, B.C. - April 14, 2014 (Investorideas.com Newswire) GLG Life Tech Corporation (TSX: GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial development of high quality natural sweeteners, announces that it has submitted a Generally Recognized as Safe ("GRAS") notification with the United States Food and Drug Administration ("FDA") for its high purity Rebaudioside M stevia extract product.

This notification represents many months of work to develop the product and all required documentation under the FDA-administered GRAS process to demonstrate that GLG's Reb M extract meets the FDA's criteria for safety. This included in-depth consultation with GRAS Associates, LLC who convened an independent panel of scientists to spearhead this safety assessment.
GLG has now prepared and submitted six GRAS filings related to its stevia extract products --- the largest number filed by any company in the world today. GLG has three other GRAS projects underway for additional high purity stevia products and Luo Han Guo products that are expected to be released for review by the FDA in 2014.
GLG has the largest number of stevia products certified under the GRAS process including rebaudioside A products ranging from purities of 50 to 97%, high purity stevioside (STV) and now high purity rebaudioside M. Additional products currently underway for additional GRAS work include high purity rebaudioside C and high purity rebaudioside D. The company is also working on a GRAS application for Luo Han Guo extracts. GLG is committed to ensuring that their ranges of naturally sourced sweetener products are fully documented to comply with the FDA GRAS process.
GLG is also working through its 2014 agriculture development program that is focused on developing new varieties of stevia leaf that will contain higher amounts of the scarcer glycosides such as Rebaudioside C, D and M --- all through Non-GMO breeding. The Company had very encouraging results with 2013's program, and plans to continue to develop some of the more interesting varieties in 2014. For example, in some of the 2013 seedlings, more than double the average of rebaudioside C and rebaudioside D was achieved while still having high glycoside weight in the leaf and high rebaudioside A content. Our products will always be naturally sourced from the stevia leaf.
About GLG Life Tech Corporation
GLG Life Tech Corporation is a global leader in the supply of high purity stevia extracts, an all-natural zero-calorie sweetener used in food and beverages. The Company's vertically integrated operations cover each step in the stevia supply chain including non-GMO stevia seed breeding, natural propagation, stevia leaf growth and harvest, proprietary extraction and refining, marketing and distribution of finished product. For further information, please visit www.glglifetech.com.
Forward-looking statements: This press release contains certain information that may constitute "forward-looking statements" and "forward looking information" (collectively, "forward-looking statements") within the meaning of applicable securities laws. Such forward-looking statements include, without limitation, statements evaluating the market, potential demand for stevia and general economic conditions and discussing future-oriented costs and expenditures. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes" or variations of such words and phrases or words and phrases that state or indicate that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.
While the Company has based these forward-looking statements on its current expectations about future events, the statements are not guarantees of the Company's future performance and are subject to risks, uncertainties, assumptions and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Such factors include amongst others the effects of general economic conditions, consumer demand for our products and new orders from our customers and distributors, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations, industry supply levels, competitive pricing pressures and misjudgments in the course of preparing forward-looking statements. Specific reference is made to the risks set forth under the heading "Risk Factors" in the Company's Annual Information Form for the financial year ended December 31, 2013. In light of these factors, the forward-looking events discussed in this press release might not occur.
Further, although the Company has attempted to identify factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
As there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements, readers should not place undue reliance on forward-looking statements.
Contact:
Stuart Wooldridge, Investor Relations
Phone: +1 (604) 669-2602 ext. 104
Fax: +1 (604) 662-8858
Email: ir@glglifetech.com
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers Disclosure: GLG Life Tech Corporation (TSX: GLG) April 9th 2014 - two months news and content publication , two thousand five hundred per month. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Biotech News Alert: Q & A Interview with C.E.O of Sunshine Biopharma (OTCQB: SBFM) Discussing Recent News of Improved Effectiveness of Lead Compound Adva-27a

New York, NY - Point Roberts, WA - April 14, 2014 (Investorideas.com Biotech Newswire) Investorideas.com, a global news source covering leading sectors including biotech and pharma, issues an exclusive Q&A interview with the CEO of Sunshine Biopharma Inc. ( OTCQB: SBFM ), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer.

Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma shares insights into recent developments with the company’s lead compound, Adva-27a.
Interview:
Q: Investorideas.com
The company recently announced improved effectiveness of your lead compound Adva-27a. Can you explain to investors what the results were and what that means moving forward?
A: Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma
We resolved the two isomeric forms of our lead anticancer compound, Adva-27a, and as a result the specific activity of the drug candidate has increased 9.5-fold. We had previously announced that the concentration at which Adva-27a inhibited 50% of the activity of Topoisomerase II, an enzyme that cancer cells use to proliferate, (IC50) was 13.7 micromolar (see press release issued on October 5, 2011). As a result of this recent laboratory development Adva-27a’s IC50 has dropped 9.5-fold, to 1.44 micromolar.
This implies that significantly lower quantities of the drug can be used to achieve the same effect. In the long run, this could also mean lower therapeutic dosages for our future breast cancer and pancreatic cancer patients, which theoretically should result in reduced side-effects.
Q: Investorideas.com
Will this improved effectiveness apply to all the cancers you are targeting or just one specific target?
A: Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma
Yes, theoretically this improved effectiveness applies to all cancer types in which Adva-27a is effective.
Q: Investorideas.com
What triggered you toresolve the two isomeric forms of your lead anticancer compound, Adva-27a?.
A: Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma
Resolving the isomeric forms of a lead compound is usually one of the matters addressed at the final stages of drug synthesis. Not all compounds have isomeric forms. Adva-27a happens to be a compound that does, owing to the presence of a carbohydrate moiety which is important for the anticancer activity of the molecule.
Q: Investorideas.com
You announced in late January that the company is now targeting pancreatic cancer as a second indication for Adva-27a, what is the significance of a second indication?
A: Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma
Pancreatic cancer has an extremely poor prognosis. Most pancreatic cancer patients will die within one year of diagnosis. Cancer of the pancreas is the fourth most common cause of cancer-related deaths in the United States. Recently, the Pancreatic Cancer Action Network released a special report entitled, ‘The Alarming Rise of Pancreatic Cancer Deaths in the United States: Why We Need to Stem the Tide Today’. The alarming findings presented in the report included the fact that by the year 2020, and possibly as early as 2015, pancreatic cancer will move from the fourth leading cause of cancer deaths to the second leading cause of cancer deaths in the United States. It is the aggressive nature and lack of effective therapy that lead us to apply Adva-27a for use against pancreatic cancer.
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
About Sunshine Biopharma Inc. ( OTCBB: SBFM )
Sunshine Biopharma is an early stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. Sunshine Biopharma recently announced that it has initiated IND-Enabling studies for its lead antitumor compound, Adva-27a, which is currently targeted for multidrug resistant cancer.
www.sunshinebiopharma.com
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Follow Investorideas.com on Twitter   http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member and use our online stock directories to research stocks - waters stocks, renewable energy, tech, mobile, mining stocks and more… http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure - Disclosure: SBFM effective December 3, 2013 news and content publication (one hundred thousand shares of 144 stock per 3 month period for a total of six months) More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
800-665-0411 -   Source - www.investorideas.com

Medical Technology Breaking News: Aethlon Medical (OTCQB: AEMD) Note: U.S. Clinical Progression

SAN DIEGO - April 9, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

In the coming months, we plan to initiate the first FDA approved study of Hemopurifier® therapy in the United States. Historically, U.S. clinical progression of extracorporeal devices directed toward a single disease indication has been a proven model for value creation.
Our clinical objectives are a bit more ambitious as we aim to navigate Hemopurifier® therapy into both cancer and infectious disease indications. Yes, we plan to file an investigational device exemption (IDE) to treat cancer later this year. We are also investigating Emergency Use Authorization (EUA) opportunities based on our broad-spectrum bioterror and pandemic threat data and have begun to explore Humanitarian Use Device (HUD) pathways for orphan conditions that affect fewer than 4,000 individuals in the U.S. each year.
To support the breadth of our long-term therapeutic vision, we often encounter challenging decisions. As an example, we recently disclosed a clinical relationship with DaVita Clinical Research, which required a lengthy process to establish and thus contributed to delay the initiation of our hepatitis c virus (HCV) feasibility study. However, the resulting relationship transitioned our potential clinical footprint from a single-site institute to an institute with more than 250 clinical sites to support long-term regulatory objectives.
Since crossing the threshold of having the FDA clear our candidate therapy for human studies, our therapeutic focus has been honed toward clinical progression to support future registration of Hemopurifier® therapy in the United States. The protocol of our forthcoming feasibility study calls for the enrollment of ten HCV-infected end-stage renal disease (ESRD) patients who have not received HCV drug therapy for at least 30 days. The protocol includes a control phase which consists of three consecutive standard dialysis treatments during week one followed by the inclusion of our Hemopurifier® for a total of six treatments administered during weeks two and three. The rate of adverse events observed during the Hemopurifier® treatment phase will be compared to the rate experienced during the control phase. Per-treatment changes of viral load will be observed through PCR analysis and we will also quantitate HCV viral copies captured within the Hemopurifier® during each treatment session. Successful completion of the feasibility study will set the stage for us to conduct pivotal efficacy studies required for Hemopurifier® market clearance. The study will also contribute data toward the human safety challenge requirement to advance the Hemopurifier® as a broad-spectrum countermeasure against viral bioterror and pandemic threats, whose lethality do not allow for the administration of clinical efficacy studies. Based on our experience conducting a similar protocol overseas, we are cautiously optimistic.
In closing, it is our sincere hope to reward shareholders whose support never wavered, even in the face of material setbacks and the clinical uncertainty of whether FDA would permit Hemopurifier® studies in the United States. As a result of this support, we have an opportunity to advance our therapeutic platform into a wide-range of life-threatening disease conditions.
About Aethlon Medical, Inc.
Aethlon Medical creates innovative medical devices to address life-threatening diseases. The Aethlon ADAPT™ (Adaptive Dialysis-like Affinity Platform Technology) establishes the basis for a new class of therapeutics that target the rapid elimination of disease enabling particles from the circulatory system of treated patients. The lead Aethlon ADAPT™ product is the Hemopurifier®, a device that addresses a broad-spectrum of viral pathogens as well as tumorsecreted exosomes that suppress the immune system of cancer patients. Aethlon is also operating under two government contracts with the Defense Advanced Research Projects Agency (DARPA) related the development of a medical device to reduce the incidence of sepsis. Exosome Sciences, Inc. is a majority owned Aethlon subsidiary that is advancing exosome-based strategies to diagnose and monitor cancer and infectious disease progression. Additional information can be found at www.AethlonMedical.com
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the ESI will not be able to commercialize its future products, that the FDA will not approve the initiation of the Company's existing or future clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, the ability of the Company to meet the milestones contemplated in the DARPA contract, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com newswire
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. Disclosure: Investorideas has been compensated by AEMD for news distribution and content publishing: 2425 quarterly for annual news publishing only starting Feb 26th 2014
http://www.investorideas.com/About/Disclaimer.asp
This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar

NXT-ID, Inc. (OTCQB: NXTD): Location Announced for Corporate Event for Wocket(TM), a Next Generation Smart Wallet; World-Renowned Plaza Hotel to Showcase Wocket's Debut on May 28th in New York City

SHELTON, CT - April 9, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, today announces the location and time of its first corporate launch event and press conference for its next generation smart wallet, Wocket™, designed to secure and replace all the cards in your wallet. The event will take place in New York City on May 28th at the world-renowned Plaza Hotel from 3:00-5:00 p.m. est.

The first hour will consist of the marketing event and press conference to be held in the Terrace Room, followed by a one hour reception in the Terrace Foyer. Attendees will include media and shareholders. The event will be recorded for viewing online for interested media, investors and consumers. Consumers will be able to pre-order online following the event.
Mr. Gino Pereira, Chief Executive Officer of NXT-ID, Inc. said of the event, "For more than one hundred years, the Plaza has held a special place in the hearts and imagination of people around the world. This event will be the beginning of a world class marketing roll-out to reflect what we believe is a game changing technology in the payment and secure identity industry. Everyone in the world knows the Plaza and what it stands for; now it's time for the world to get to know Wocket™ and the standard of excellence we want to project."
Pereira continued, "It was once said, 'Nothing unimportant ever happens at The Plaza.' We can't imagine a better destination to introduce Wocket™, its new brand image and identity, new packaging, our new video and the commencement of pre-orders."
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
The event will give consumers and media a first-hand look at the Wocket™ Smart Wallet, the Wocket™ Card, its new logo and brand images, new consumer video and new packaging. Following the event, consumers will be able to pre-order Wocket™ online.

Introducing Wocket™ at the Plaza will be Mr. Gino Pereira, Chief Executive Officer of NXT-ID, and Inc., David Tunnell, Chief Technology Officer and Advisory Board member, Mr. Lawrence Flanagan, the former Global Chief Marketing Officer of MasterCard. Mr. Flanagan managed a $1.5 billion budget, directed marketing strategies in more than 50 countries and helped launch the company's hugely successful, "Priceless" advertising campaign.
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
Interested consumers can also sign up for product info and news alerts in anticipation of the product. http://www.thewocket.com/ and http://www.wocketwallet.com/
About the Plaza events http://www.theplazany.com/ and http://www.theplazany.com/events/
History: http://www.theplazany.com/history/
The event is limited to one hundred attendees consisting of media and shareholders. To attend please send requests to info@nxt-id.com or call 800 665 0411.
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™ ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
ksmith@proactivecapital.com
Media: 800 665-0411

Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Frac Water News Alert: HII Technologies, Inc. (OTCBB/OTCQB: HIIT) Announces Preliminary First Quarter 2014 Results

HOUSTON - April 8, 2014 (Investorideas.com Newswire) HII Technologies, Inc. (the "Company"), symbol HIIT (OTCBB/OTCQB: HIIT), an oilfield services company focused on providing Water, Power and Safety Services with operations in Texas, Oklahoma, Ohio and West Virginia today announced that its preliminary unaudited results for consolidated revenues from operations for the quarter ended March 31, 2014 exceeded $6.5 million.

On a consolidated basis, the Company's revenues for the quarter ended March 31, 2014 were approximately $6.5 million, an increase of over 150% compared to the first quarter 2013 consolidated revenues of $2.6 million. Further, the Company's preliminary first quarter 2014 revenues represented a sequential increase of approximately 35% from the Company's fourth quarter 2013 revenues, which were approximately $4.8 million.
Mr. Flemming, CEO HII Technologies, stated, "Our growth continued in the first quarter of 2014 resulting from continued activity levels in the markets we serve including the Permian, Eagle Ford Shale, Eaglebine and Utica shale areas. During the quarter, significant developments occurred in all three of our divisions. In the Water division, AES Water Solutions has provided a waste water evaporation service to some leading E & P companies in the Eagle Ford and Permian Basin areas and AquaTex has gained several new customers expanding in the Eaglebine area. AES Safety Services is now providing rapid response site remediation for customers' environmental incidents. And in our Power division, STP has expanded its equipment and rental fleet as well as geographic expansion into the Permian Basin with additional new customers."
The Company anticipates filing its Quarterly Report on Form 10-Q for the period ended March 31, 2014 and announcing earnings and related financial results for the period by May 15, 2014.
About HII Technologies, Inc.
HII Technologies, Inc. is a Houston, Texas based oilfield services company with operations in Texas, Oklahoma, Ohio and West Virginia. By focusing on the Water, Power and Safety oilfield segments, the Company is positioned to take advantage of the anticipated, significant growth in horizontal drilling and hydraulic fracturing within the United States' active shale and unconventional "tight oil" plays. The Company's frac water supply and flow back services segment has two subsidiaries, AES Water Solutions and AquaTex, its onsite oilfield contract safety consultancy does business as AES Safety Services, and its mobile oilfield power subsidiary operates as South Texas Power (STP). HII Technologies' objective is to bring proven technologies to these operating divisions to build a long-term competitive advantage. Read more at www.HIITinc.com, www.AESwatersolutions.com, www.AquaTexUSA.com, www.AESSafetyServices.com and www.Oilfield-Generators.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements as to matters that are not of historic fact are forward-looking statements. These forward-looking statements are based on HII Technologies, Inc. ("HII")'s current expectations, estimates and projections about HII, its industry, its management's beliefs and certain assumptions made by management, and include statements regarding estimated capital expenditures, future operational and activity expectations, international growth, and anticipated financial performance in 2014. No assurance can be given that such expectations, estimates or projections will prove to have been correct. Whenever possible, these "forward-looking statements" are identified by words such as "expects," "believes," "anticipates" and similar phrases.
Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, but not limited to: risks that HII will be unable to achieve its financial, capital expenditure and operational projections, including quarterly and annual projections of revenue and/or operating income and risks that HII's expectations regarding future activity levels, customer demand, and pricing stability may not materialize (whether for HII as a whole or for geographic regions and/or business segments individually); risks that fundamentals in the U.S. oil and gas markets may not yield anticipated future growth in HII's businesses, or could further deteriorate or worsen from the recent market declines, and/or that HII could experience further unexpected declines in activity and demand for its hydraulic frac related water transfer business, its safety consultancy business or its generator and related equipment rental service businesses; risks relating to HII's ability to implement technological developments and enhancements; risks relating to compliance with environmental, health and safety laws and regulations, as well as actions by governmental and regulatory authorities. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Other important risk factors that may affect HII's business, results of operations and financial position are discussed in its most recently filed Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K and in other Securities and Exchange Commission filings. Unless otherwise required by law, HII also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. However, readers should review carefully reports and documents that HII files periodically with the Securities and Exchange Commission.
Because such statements involve risks and uncertainties, many of which are outside of HII's control, HII's actual results and performance may differ materially from the results expressed or implied by such forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Other important risk factors that may affect HII's business, results of operations and financial position are discussed in its most recently filed Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K and in other Securities and Exchange Commission filings. Unless otherwise required by law, HII also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. However, readers should review carefully reports and documents that HII files periodically with the Securities and Exchange Commission.
Contact:
Matthew Flemming, HII Technologies, Inc. +1-713-821-3157
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
HIIT disclosure: March 2013: two thousand per month for profile and news publication, renewed August 2013: five hundred per month for news publication
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

NXT-ID (OTCQB: NXTD) Media Alert: Trend Hunter Card Generating Smart Wallet Article Looks at The Wocket™

SHELTON, CT - April 8, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD) a biometrics company focused on the growing m-commerce market is featured today on Trend Hunter ( www.trendhunter.com ).

With 60,000,000 monthly views, TrendHunter.com is the world's largest, most popular trend community. Trend Hunter is based in Toronto, Canada, and fueled by a global network of 139,000 members and 3,000,000 fans.
The article titled "The 'Wocket' Generates Electronic Versions of Debit and Credit Cards" can be read in its entirety at http://www.trendhunter.com/trends/wocket .
Excerpt:
The 'Wocket' Generates Electronic Versions of Debit and Credit Cards
Trend Hunter
The Wocket is a high-tech smart wallet designed to securely store electronic versions of your various plastic cards so you don't have to carry physical cards everywhere and risk losing them or having them stolen.
The Wocket also comes with a swipeable physical card that can be programmed for single uses. It can also be purchased with the option of an added cash-carrying accessory.
Read the full article at: http://www.trendhunter.com/trends/wocket
Other Recent Media Coverage:
Nxt-ID to Release Biometric Smart Wallet
Chain Store Age - Nxt-ID Inc. intends to launch a smart wallet called Wocket. A biometrically secure smart wallet with a smart card that is immediately zeroized after each transaction, Wocket is designed to be useless to a thief.
Full article: www.chainstoreage.com/article/nxt-id-release-biometric-smart-wallet
Wocket Wants to Replace Your Wallet
Gizmag - No one wants their credit or debit cards, or even their NFC-enabled smartphone falling into the wrong hands. While there are already various security measures in development, NXT-ID's Wocket is one of the latest. Described as a "smart wallet," it's designed to securely store electronic versions of your various cards, plus it features a swipe-able physical card that can be programmed for single uses.
Full Article: http://www.gizmag.com/wocket-smart-wallet/31477/
Will Wocket™ Wow Digital Payments?
PYMTS.COM - W ill hype alone be able to carry the mobile-payments market? A Shelton, Conn.-based company apparently believes so. It also believes the phone is unnecessary to bring "mobile" eWallet payments to the masses.
Full Article: http://www.pymnts.com/in-depth/2014/will-wocket-wow-digital-payments/#.Uzw3dvldXC9
"Piquing our Geek: The Wocket Wallet could be the future of smart wallets"
CoolMomTech.com - I'm completely on the The best wearable tech bandwagon, but I'm definitely still skeptical about the whole smart wallet concept. That doesn't mean I've written it off completely, which why I'm very intrigued reading about the new Wocket Wallet.
Full Article: http://coolmomtech.com/2014/02/wocket-smart-wallet/ .
"The World of Wallets is About to Change"
The Housing Hour - The world of wallets is about to change. New exciting technologies are making payments easier than ever. However, many credit card holders either do not possess a smartphone or will be reluctant to use their smartphone for mobile payments due to a variety of reasons.
Full Article: http://www.thehousinghour.com/2014/02/
"Retailers Try to Keep Pace With Cybercriminals"
WSJ-Risk & Compliance Journal-Other companies are touting products they say are superior to--and less costly than–pin-and-chip technology. Biometrics company NXT-ID this month announced a checkout technology it said secures payment information before, during and after a transaction, and renders useless any credit card information a criminal may steal in a breach. Software development company Monkeetech last year announced a card fraud prevention system that requires the consumer to undergo an iris scan to prove their identity.
Full Article:
http://blogs.wsj.com/riskandcompliance/2014/01/28/retailers-try-to-keep-pace-with-cybercriminals/
"Coin vs.The Wocket A Battle for Your Bulging Wallet"
Americanlivewire.com - You may have heard something lately about something called Coin, thanks to an aggressive social media and deep intro discount pricing campaign currently underway. Perhaps you have heard of The Wocket, which claims to be a "biometrically secure device"? Both products are pure genius and aim to replace your bulging wallet with their single slick all-in-one card. Since they are so similar, here's a closer look and comparison of Coin vs.The Wocket, A Battle For Your Bulging Wallet.
Full article: http://americanlivewire.com/coin-vs-the-wocket/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The   company  is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™, a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.   http://www.thewocket.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com /, http://3d-id.net/
Contacts:

NXT-ID, Inc.
Corporate info: info@nxt-id.com , http://www.nxt-id.com/
Published at Investorideas.com
About www.InvestorIdeas.com : Big Ideas for global investors
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors.
Research Biometrics Stocks at Investorideas.com stock directory
http://www.investorideas.com/BPS/Stock_List.asp
Sign up for free stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer / Disclosure: This email and content is for subscribers /investors at Investorideas and not for duplication and publication on other websites or blogs. If you would like to publish any content sent from investorideas email please send us a written request. Publication of our email alerts without written permission will be considered a violation of our copyright. The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights.  Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013: Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous service. More info : http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country.
Become an Investorideas.com Member and access our 14 online stock directories 24/7 -mining stocks, oil and gas stocks and more...
http://www.investorideas.com/membership/
Any redistribution or publishing of information from our newsletter alerts and e-mails without the written consent of Investorideas.com is strictly forbidden 

Biotech News Alert: Sunshine Biopharma (OTCQB: SBFM) Increases the Effectiveness of Adva-27a Lead Compound 9.5-Fold Against Breast and Pancreatic Cancer in Vitro

Montreal, Quebec - April 7, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer today announced that it has resolved the two isomeric forms of its lead anticancer compound, Adva-27a, and as a result the specific activity of the drug candidate has increased 9.5-fold. Sunshine Biopharma had previously announced that the concentration at which Adva-27a inhibited 50% of the activity of Topoisomerase II (IC50) was 13.7 micromolar (see press release issued on October 5, 2011). As a result of today's development Adva-27a's IC50 has dropped 9.5-fold, to 1.44 micromolar. This implies that significantly lower quantities of the drug can be used to achieve the same effect.

"Isomeric forms of a compound refer to the fact that the compound has different arrangements of its atoms in space," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "Isomeric forms do not have identical properties. In the case of Adva-27a, the molecule exists in the alpha or beta form. This is a lot like a person's left hand and right hand. While the two hands look identical, they actually are not. They are mirror images of each other but are not superimposable. The fact that they are not superimposable means that they are not identical. Similarly, the alpha and beta forms of Adva-27a are not superimposable. The implications of all of this for our future breast cancer and pancreatic cancer patients are lower therapeutic dosages, which theoretically should result in reduced side-effects."
About Adva-27a
Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935. The Company is planning a Phase I clinical trial of Adva-27a for pancreatic cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant breast cancer to be conducted at McGill University's Jewish General Hospital in Montreal (Canada).
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Updates Santa Elena Mine Expansion Plan

Vancouver, British Columbia - April 7, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to provide an update on activities for the expansion of the Santa Elena Mine in Sonora, Mexico. The Santa Elena Mine expansion is on budget (+/-5%) with initial start up of the new 3000 tpd operation anticipated later this month. The most significant activities are outlined below. For additional information and to view photos and videos, please visit the Company's website at www.silvercrestmines.com.

N. Eric Fier, President and COO stated; "We are pleased with the final stages of the Santa Elena Expansion Plan which will significantly increase our precious metal production starting in mid-2014. Previous delay in delivery of the ball mill has pushed back our original Q1 start up to early Q2 while remaining on budget. The start up of the mill this month will be a major milestone for SilverCrest. The Company continues to grow as a low cost junior operator transitioning into a successful mid-tier precious metal producer. As part of a revised start up schedule we have elected to discontinue open pit operations and accelerate underground operations. These operational changes may have some impact on Q2 production but no change to the previously announced 2014 corporate production guidance of 3.3 to 3.6 million ounces AgEq (60:1)."
Santa Elena Expansion Plan

• New CCD/Merrill Crowe processing plant is 96% complete with final electrical and piping work being completed and tested over the next two weeks.
• 80% of the major equipment has been tested and passed for initial start up. The remaining 20% will be tested during start up.
• FLSmidth, the primary equipment supplier, has representatives on site supervising final work in anticipation of mill commissioning over the next 3 months.
• Ore feed during the mill commissioning period will come from a blend of high grade underground ore and the upper part of the leach pad which represents the last 6 months of high grade open pit production that has only received partial leaching.
• As planned with mill start up, no further ore will be loaded on the leach pad but gold and silver production will continue at a diminishing rate from the pad until at least August, 2014.
• As part of the previously announced transition to underground mining, open pit operations have ceased as of April 4, 2014 which is approximately 3 months ahead of original schedule. Operational constraints presented by the mine contractor amongst other factors have triggered this early cessation of pit operations. Remaining open pit reserves are readily accessible from the 700m and 675m underground planned levels and the Company is scheduling retrieval of these reserves at a later date. Total reserves are unaffected by cessation of the pit operations.
  
  Underground mining and development has been accelerated providing access to high grade ore feed to the mill over the next 3 months to replace ore that was expected from planned open pit production. From May through July (mill commissioning period), underground ore feed to the mill will come from increased ore development at a rate of 20,000 to 25,000 tonnes per month (previously 5,000 tpm). Underground ore will be blended with leach pad ore to achieve nameplate mill capacity of 3,000 tpd by July 2014. Key underground personnel are in place to execute the accelerated underground operations.
• Underground equipment for owner operated production is expected to arrive on site in early May and initial production stoping is scheduled for late June or early July 2014.
• Decline access work continues with approximately 2,400 metres of the main ramp driven to date (570m level). The 575m level is planned for 1st stope production.

Despite the operational changes in mine schedule of early pit closure and accelerated underground operations, the Company maintains previously announced 2014 corporate production guidance of 3.3 to 3.6 million ounces AgEq (60:1) will be unchanged.
The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (NYSE MKT:SVLC; SVL.TO)
is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and operating cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State, Mexico.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
N. Eric Fier, President & COO
SILVERCREST MINES INC.
Neither TSX Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Fred Cooper
Telephone: (604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
Email: info@silvercrestmines.com
Website: www.silvercrestmines.com
Address: Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894